MEDIANTECHNOLOGIES news, videos and press releases - Page 4
For more news please use our advanced search feature.
MEDIANTECHNOLOGIES - More news...
MEDIANTECHNOLOGIES - More news...
- Median Technologies: Financial Communications Schedule for the First Half of 2022
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2021
- Median Technologies Announces New Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 With a Focus on Stage 1 Lung Cancer Characterization
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2021
- Median Technologies Reports on Its 2021 Half-Year Results and Its Q3 2021 Business Activity Indicators
- Median Technologies to Host a Live Webcast and Provide a Company Update on October 25th, 2021
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30th, 2021
- Median Technologies Has Been Confirmed as a Preferred Vendor by one of the Top 3 Pharmaceutical Companies in the World, and Selected to Implement Their Clinical Trial Imaging Strategy on Some Key Oncology Indications
- Median Technologies Changes the Publication Date of Its H1 2021 Results
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31st, 2021
- Median Technologies Announces Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 to Accurately Characterize Malignant vs Benign Lung Nodules Based on a Large-scale Patient Cohort
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31st, 2021
- Median Technologies Appoints Jean-Christophe Montigny as Chief Financial Officer and Member of the Executive Committee
- Half Year Median Technologies Liquidity Contract Statement Contracted With TP ICAP (Europe)
- Median Technologies: Financial Communication Schedule for the Second Half Of 2021
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30th, 2021
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31st, 2021
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30th, 2021
- Median Technologies : Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31st, 2021
- Median Technologies Is Releasing Full Year 2020 Financial Results (audited) as Well as Q1 2021 Business Activity Indicators, Showing a Very Strong Growth
- Median Technologies: Highly Successful Capital Increase via a Private Placement of 28.1 Million Euros
- Median Technologies Launches a Capital Increase via a Private Placement
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of February 28th, 2021
- Median Technologies to Host a Live Webcast and Provide a Company Update on March 9th, 2021
- Median Strengthens its iBiopsy® Leadership Team With the Appointment of Thomas Bonnefont as Chief Operating and Commercial Officer and the Appointment of Mike Doherty as Sr. Strategy Advisor, Product Development
- iBiopsy®: Median Technologies Continues Its Strong Positioning in Early-Stage Diagnosis with a New iBiopsy® Clinical Development Plan on Lung Cancer Screening (LCS)
- iBiopsy®: Median Technologies Inks a Major Research Collaboration Agreement With the University of California San Diego (UC San Diego)
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31st, 2021
- Median Technologies: Half Year Liquidity Contract Statement
- Median Technologies Records a 51 % Increase of Its 2020 Annual Revenue (Unaudited Figures)
